The 20 Best Macular Corneal Dystrophy Type 1 Doctors Near Me

John D. Gottsch, M.D., is the Margaret C. Mosher Professor of Ophthalmology at the Wilmer Eye Institute. Dr. Gottsch specializes in the management of hereditary corneal disorders such as Fuchs' dystrophy, the surgical treatment of cataract and complications of cataract surgery, and corneal transplantation surgery. His clinical practice involves the medical treatment of allergic eye diseases and severe corneal inflammation from rheumatoid and other related disorders, including Mooren''s ulcer. His research interests include determining the gene expression of the cornea and the genetic basis for hereditary corneal diseases such as Fuchs' dystrophy. Dr. Gottsch is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Cataract, and Corneal Transplant.

Francis Price is an Ophthalmologist in Indianapolis, Indiana. Dr. Price is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Dr. David Hwang is an ophthalmologist specializing in corneal, cataract and refractive surgery. He has special interests in ocular infectious diseases, corneal endothelial dystrophies and diseases (conditions in which one of the cornea's layers is breaking down), and high-risk corneal transplantation. He is committed to developing innovative techniques and instruments for ophthalmologic surgery. In research, Hwang's work includes translational endeavors – applying new information from studies to patient care – for corneal endothelial diseases. In particular, he has looked at cellular transplantation and gene therapy approaches to treatment. A native of Illinois, Hwang obtained both his undergraduate and medical degrees from UCSF, graduating first in his medical school class. After a two-year residency in internal medicine and a three-year residency in ophthalmology, both at UCSF, he completed concurrent fellowships in cornea and refractive surgery and in uveitis at the Doheny Eye Institute. In 1990, Hwang joined the faculty at UCSF, where he is the Pearl T. Kimura and Samuel J. Kimura Endowed Chair in Ophthalmology. He also serves as co-director of UCSF's cornea and refractive surgery services, and holds a joint appointment as associate of the UCSF Francis I. Proctor Foundation for Research in Ophthalmology. He has served as UCSF's medical director of ophthalmology and as medical eye bank director of UCSF's tissue bank. Hwang has served in leadership and executive roles in a number of professional organizations, including president of the Ocular Microbiology and Immunology Group, and executive secretary of the Max Fine Cornea Society. For the American Academy of Ophthalmology (AAO) and Centers for Disease Control and Prevention, he chaired a joint task force on the use of vancomycin in ophthalmology. He served on the writing committee for the AAO's Basic and Clinical Science Course's volume on cornea and external eye disease, authoring and editing the section on ocular infectious and external eye disease. The American Academy of Ophthalmology has honored Hwang with awards, including the Senior Achievement Award. He has been named to the Castle Connolly America's Top Doctors list every year since 1996. He has published more than 100 scientific papers and abstracts, and co-authored two texts on cornea and refractive surgery. A committed educator, Hwang is active in teaching UCSF medical students, residents and fellows. He has received the Kimura Award for Excellence in Teaching from the UCSF Department of Ophthalmology. Hwang lives in the San Francisco Bay Area with his wife, who is also an ophthalmologist, and their three sons. Dr. Hwang is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Keratoconus, Corneal Dystrophy and Perceptive Deafness, and Corneal Transplant.

Ula Jurkunas is an Ophthalmologist in Boston, Massachusetts. Dr. Jurkunas is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Her top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy.

Naoki Okumura practices in Kyotanabe, Japan. Mr. Okumura is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Stomach Cancer, Corneal Transplant, and Gastrectomy.

Petra Liskova practices in Prague, Czech Republic. Ms. Liskova is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Her top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Congenital Cataract, Corneal Dystrophy and Perceptive Deafness, and Corneal Transplant.

Noriko Koizumi practices in Kyotanabe, Japan. Ms. Koizumi is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Her top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy.

Anthony Aldave is an Ophthalmologist in Los Angeles, California. Dr. Aldave is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Keratoconus, Fuchs Dystrophy, Corneal Transplant, and Trabeculectomy.

Friedrich Kruse practices in Erlangen, Germany. Mr. Kruse is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Glaucoma, Corneal Transplant, and Cataract Removal.

Ursula Schrehardt-Schlotzer practices in Erlangen, Germany. Ms. Schrehardt-Schlotzer is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Her top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Glaucoma, Corneal Transplant, and Cataract Removal.

Keith Baratz is an Ophthalmologist in Rochester, Minnesota. Dr. Baratz is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Aniridia, Corneal Transplant, and Cataract Removal.

Theofilos Tourtas practices in Erlangen, Germany. Mr. Tourtas is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Keratomalacia, Corneal Transplant, and Cataract Removal.

Katrin Wacker practices in Freiburg, Germany. Ms. Wacker is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Her top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Lubica Dudakova practices in Prague, Czech Republic. Dudakova is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Their top areas of expertise are Macular Corneal Dystrophy Type 1, Corneal Dystrophy and Perceptive Deafness, Fuchs Dystrophy, Congenital Cataract, and Corneal Transplant.

Kohji Nishida practices in Osaka, Japan. Nishida is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. Their top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Keratoconus, Vitrectomy, and Corneal Transplant.

Mario Matthaei practices in Koeln, Germany. Mr. Matthaei is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Keratoconus, Corneal Transplant, and Cataract Removal.

Stephen Tuft practices in London, United Kingdom. Mr. Tuft is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Keratoconus, Corneal Transplant, and Vitrectomy.

Yoshinori Oie practices in Suita, Japan. Mr. Oie is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Astigmatism, Corneal Transplant, and Trabeculectomy.

Shigeru Kinoshita practices in Kyoto, Japan. Mr. Kinoshita is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Stevens-Johnson Syndrome, Erythema Multiforme, Fuchs Dystrophy, Corneal Transplant, and Trabeculectomy.